Importantly, our studies provide new opportunities to develop apoptotic cancer cell therapy or alternative non-cell-based therapies, such as the CM/CM compositions that include exosomal PTEN and PPARγ ligands, as an effective antimetastasis tool in a variety of experimental and clinical settings. This evidence concerns the gene PPARG and cancer.